Gene-Testing Dispute Focuses on How Much a Patient Should Know

Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don’t request the information?

To continue reading this article you must be a Bloomberg Professional Service Subscriber.